1 completed, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow ferrous citrate: new trials by email Literature Review of ferrous citrate trials Research Report on ferrous citrate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery 5-Aminolevulinic Acid hydrochloride (5-ALA), Placebo, Sodium ferrous citrate (SFC) - Cardiac Surgical Procedures, Coronary Artery Bypass | Phase 2 | Completed | University of Oxford | 48 | 2021-02-01 | 2025-06-25 |
| A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria 5-aminolevulinic acid hydrochloride (5-ALA HCl) 600 mg QD, Sodium ferrous citrate (SFC) 472 mg QD, Artemisinin-based combination (ACT) - Malaria | Phase 2 | Withdrawn | Neopharma Japan Co., Ltd. | 2019-09-06 | 2020-03-03 |
Aortic Valve Disease (1) · Malaria (1)
Neopharma Japan Co., Ltd. (1) · University of Oxford (1)
United Kingdom (1)